M-CENK

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameM-CENK

Drug Alias NameM-CENK

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Memory like NK cell therapy

Mechanisms of ActionNatural killer cell replacementsImmunologic cytotoxicity

TargetsNot applicable

Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesImmunitybio Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmunitybio Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursOvarian Neoplasms

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A